Repurposing of nitroxoline as a potential anticancer agent against human prostate cancer - a crucial role on AMPK/mTOR signaling pathway and the interplay with Chk2 activation

Wei‐Ling Chang(National Taiwan University), Jih‐Hwa Guh(National Taiwan University)

Oncotarget

October 3, 2015

10.18632/oncotarget.5655

Cited by 49

Related Papers

2‐Phenyl‐5‐(pyrrolidin‐1‐yl)‐1‐(3,4,5‐trimethoxybenzyl)‐1 <i>H</i> ‐benzimidazole, a benzimidazole derivative, inhibits growth of human prostate cancer cells by affecting tubulin and c‐Jun N‐terminal kinase

|British Journal of Pharmacology|2010|28

Reevesioside A, a Cardenolide Glycoside, Induces Anticancer Activity against Human Hormone-Refractory Prostate Cancers through Suppression of c-myc Expression and Induction of G1 Arrest of the Cell Cycle

|PLoS ONE|2014|28

Phosphodiesterase Type 5 Inhibitors Synergize Vincristine in Killing Castration-Resistant Prostate Cancer Through Amplifying Mitotic Arrest Signaling

|Frontiers in Oncology|2020|26

<i>Epi</i>-reevesioside F inhibits Na+/K+-ATPase, causing cytosolic acidification, Bak activation and apoptosis in glioblastoma

|Oncotarget|2015|11

Mechanism Studies of Antitubulin Agents-mediated MMP Down-regulation and Nitroxoline Repurposing in Human Prostate Cancer Cells

|OhioLink ETD Center (Ohio Library and Information Network)|2015|0